DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the company will sponsor a symposium on Thursday, Sept. 23, 2010 during the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference in Washington, D.C.
